首页> 中文期刊>中国病理生理杂志 >pEZRThr567在肺鳞癌中的表达及临床病理学意义

pEZRThr567在肺鳞癌中的表达及临床病理学意义

     

摘要

目的:探讨第567位苏氨酸磷酸化的埃兹蛋白(pEZRThr567)在肺鳞癌、癌旁及正常肺组织中的表达及其临床病理学意义。方法:用免疫组化法检测pEZRThr567在肺癌、癌旁及正常肺组织中的表达,并分析其异常表达与临床病理学特点之间的相关性;用免疫荧光染色法检测pEZRThr567在肺鳞癌细胞EBC-1中的定位情况。结果:pEZRThr567蛋白在肺鳞癌组织中的表达明显高于癌旁组织和正常肺组织(P<0.01);pEZRThr567蛋白主要表达于细胞膜,且其表达与肿瘤分化程度、临床分期和有无淋巴结转移密切相关(P<0.05)。结论: pEZRThr567蛋白可作为肺鳞癌恶性进展的有效分子指标。%AIM:To investigate the clinicopathological significance of the protein expression of phosphorylated ezrin at threonine 567 ( pEZRThr567 ) in lung squamous cell carcinoma, adjacent tissues and normal tissues.METHODS:pEZRThr567 protein was detected in lung squamous carcinoma, adjacent and normal tissues by the method of immunohisto-chemistry.The correlation of pEZRThr567 expression with clinicopathological parameters of lung squamous carcinomas was al-so analyzed.The localization of pEZRThr567 was detected by immunofluorescence staining in lung squamous cell line EBC-1. RESULTS:The protein expression of pEZRThr567 in lung squamous carcinoma was significantly higher than that in the adja-cent and normal lung tissues (P<0.01).pEZRThr567 mainly localized on the cell membrane, and its over-expression signi-ficantly correlated with the differentiation, clinical stage and lymph node metastasis in lung squamous carcinoma.CON-CLUSION:pEZRThr567 may be an effective biomarker for prediction of malignant potential and poor prognosis of lung cancer.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号